A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution

Tsujinaka Aika; Takai Yasuyuki; Inoue Yoshitsugu; Tanito Masaki

首页> 外文期刊>Acta ophthalmologica >A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution

【24h】

A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution

机译：使用多种抗原瘤药物后双侧深层角膜不透明度和血管形成的情况，包括吡啶胺酒石酸酯眼科溶液

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Acta ophthalmologica》 |2019年第6期|共3页
作者
Tsujinaka Aika; Takai Yasuyuki; Inoue Yoshitsugu; Tanito Masaki;
展开▼
作者单位

Department of OphthalmologyShimane UniversityIzumo Japan;

Department of OphthalmologyShimane UniversityIzumo Japan;

Division of Ophthalmology and Visual ScienceTottori UniversityYonago Japan;

Department of OphthalmologyShimane UniversityIzumo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
专利

1. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution [J] . Tsujinaka Aika, Takai Yasuyuki, Inoue Yoshitsugu, Acta ophthalmologica . 2019,第6期

机译：使用多种抗原瘤药物后双侧深层角膜不透明度和血管形成的情况，包括吡啶胺酒石酸酯眼科溶液
2. Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use [J] . Maruyama Yuko, Ikeda Yoko, Yokoi Norihiko, Cornea . 2017,第12期

机译：亚胺尼胺酒石酸酯眼科溶液使用发生严重的角膜障碍
3. Vitreous and Aqueous Concentrations of Brimonidine Following Topical Application of Brimonidine Tartrate 0.1% Ophthalmic Solution in Humans [J] . Takamura Yoshihiro, Tomomatsu Takeshi, Matsumura Takehiro, Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics . 2015,第5期

机译：在人体局部应用酒石酸溴莫尼定0.1％眼药水后溴莫尼定的玻璃和水溶液浓度
4. Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate [O] . Yuka Kasuya, Ichiya Sano, Shinji Makino, 2020

机译：通过溴蒙丁以外的抗原瘤剂诱导的角膜不透明度
5. Evaluation of Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution, 0.025 for Treatment of Ocular Redness [O] . Gail L. Torkildsen, Christine M. Sanfilippo, Heleen H. DeCory, 2017

机译：吡蒙胺酸钾眼科溶液的疗效和安全性评价，0.025％用于治疗眼发红

A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution

著录项

相似文献

相关主题

期刊订阅